ConductScience.org, home

Paper7544516

Worldwide patterns of prevalence and mortality from benign prostatic hyperplasia.

Napalkov P and 2 others. Urology, 1995. Cited by 58 papers, by iCite.

Cite this record

ConductScience Library. Worldwide patterns of prevalence and mortality from benign prostatic hyperplasia. Papers, record 7544516. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/7544516

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Worldwide patterns of prevalence and mortality from benign prostatic hyperplasia.
PubMed
Journal
Urology
PubMed
Year
1995
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't, Review
PubMed
Citations, by iCite
58
iCite
Relative citation ratio, by iCite
2.44
iCite
Revised in PubMed
2022-03-31
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Napalkov PP
2Maisonneuve PP
3Boyle PP

Source PubMed

Download CSV of authors

Topics6

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Prostatic HyperplasiaMajor topic
Global Health
Humans
Male
Prevalence
Risk Factors

Cited by16

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 58 citations.

PMIDTitleJournalYearIn PapersSource
42337003Perceived partner responsiveness between benign prostatic hyperplasia's symptom index and aging male symptoms.Sci Rep2026https://conductscience.org/library/papers/42337003PubMed
42174115Antifibrotic therapy for Lower Urinary Tract Symptoms secondary to Benign Prostatic Hyperplasia.Prostate Cancer Prostatic Dis2025https://conductscience.org/library/papers/42174115PubMed
38298771
Incidence of Surgical Reintervention for Benign Prostatic Hyperplasia Following Prostatic Urethral Lift, Transurethral Resection of the Prostate, and Photoselective Vaporization of the Prostate: A TriNetX Analysis.
Eur Urol Open Sci2024https://conductscience.org/library/papers/38298771PubMed
36821011Safety and efficacy of GreenLight PVP in octogenarians: evaluation of the Global GreenLight Group database.World J Urol2023https://conductscience.org/library/papers/36821011PubMed
33425801Evaluation of the pharmacokinetics and food effects of a novel formulation tamsulosin 0.4 mg capsule compared with a 0.2 mg capsule in healthy male volunteers.Transl Clin Pharmacol2020https://conductscience.org/library/papers/33425801PubMed
32110593Study of correlation of urodynamic profile with symptom scoring and ultrasonographic parameters in patients with benign prostatic hyperplasia.J Family Med Prim Care2020https://conductscience.org/library/papers/32110593PubMed
31218458Cost Comparison of Benign Prostatic Hyperplasia Treatment Options.Curr Urol Rep2019https://conductscience.org/library/papers/31218458PubMed
30710233The effects of Pueraria mirifica extract, diadzein and genistein in testosterone-induced prostate hyperplasia in male Sprague Dawley rats.Mol Biol Rep2019https://conductscience.org/library/papers/30710233PubMed
30608454Herbal medicine for benign prostatic hyperplasia: A protocol for a systematic review of controlled trials.Medicine (Baltimore)2019https://conductscience.org/library/papers/30608454PubMed
25491675
Demographic and comorbidity profile of patients with lower urinary tract symptoms suggestive of benign prostatic hyperplasia in a real-life clinical setting: Are 5-alpha-reductase inhibitor consumers different?
World J Urol2015https://conductscience.org/library/papers/25491675PubMed
22496707The effects of transurethral resection of the prostate on morbidity and mortality in patients with nondialysis-requiring renal insufficiency.Ther Adv Urol2012https://conductscience.org/library/papers/22496707PubMed
215572685α-reductase type 3 expression in human benign and malignant tissues: a comparative analysis during prostate cancer progression.Prostate2011https://conductscience.org/library/papers/21557268PubMed
19545384The psychometric validation of a US English satisfaction measure for patients with benign prostatic hyperplasia and lower urinary tract symptoms.Health Qual Life Outcomes2009https://conductscience.org/library/papers/19545384PubMed
17516689Efficacy of low-dose tamsulosin on lower urinary tract symptoms suggestive of benign prostatic hyperplasia : a nonblind multicentre korean study.Clin Drug Investig2004https://conductscience.org/library/papers/17516689PubMed
17341729A prostate-specific antigen-activated channel-forming toxin as therapy for prostatic disease.J Natl Cancer Inst2007https://conductscience.org/library/papers/17341729PubMed
16985831Dutasteride: a review of current data on a novel dual inhibitor of 5alpha reductase.Rev Urol2005https://conductscience.org/library/papers/16985831PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/7544516

GET https://conductscience.org/api/papers/v1/7544516/authors